Coegin Pharma AB (NGM:COEGIN)
Sweden · Delayed Price · Currency is SEK 3.000
+0.080 (2.74%)
At close: Sep 8, 2026
Coegin Pharma AB Revenue
Coegin Pharma AB had revenue of 62.00K SEK in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 433.00K. In the year 2025, Coegin Pharma AB had annual revenue of 79.00K.
Revenue (ttm)
433.00K
Revenue Growth
n/a
P/S Ratio
198.09
Revenue / Employee
n/a
Employees
3
Market Cap
85.77M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 79.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NGS Group AB | 272.33M |
| Lohilo Foods AB | 210.13M |
| Solution International Nordics AB | 122.52M |
| Mediacle Group AB | 51.56M |
| Adverty AB | 40.92M |
| Amido AB | 39.41M |
| Ramlösa shipping AB | 15.91M |
| Suntrade Group AB | 7.68M |
Coegin Pharma AB News
- 21 days ago - Coegin Pharma AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Coegin Pharma AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Coegin Pharma AB Quarterly report: Q4 2025 - Filings
- 6 months ago - Coegin Pharma AB Annual report: Q4 2025 - Filings
- 9 months ago - Coegin Pharma AB Quarterly report: Q3 2025 - Filings